Finance

Lists
Why is NKTR up 2,20%?
Dive Deeper
NKTR:NASDAQ
Nektar Therapeutics
60,54 $
+2,20%
(+1,30) 1D
61,20 $
+1,08% (+0,66)
After hours
Closed: 30 սեպ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTR...
Open
59,96 $
High
62,40 $
Low
58,91 $
Mkt. cap
2,07 մլրդ
Avg. vol.
1,09 մլն
Volume
1,21 մլն
52-wk high
109,00 $
52-wk low
33,40 $
EPS
-6,69 $
Beta
1,14
Shares outstanding
34,14 մլն
No. of employees
63
Open
59,96 $
High
62,40 $
Low
58,91 $
Mkt. cap
2,07 մլրդ
Avg. vol.
1,09 մլն
Volume
1,21 մլն
52-wk high
109,00 $
52-wk low
33,40 $
EPS
-6,69 $
Beta
1,14
Shares outstanding
34,14 մլն
No. of employees
63
News stories
From web sources and news partners
About Nektar Therapeutics
CEO-
Employees63
Founded1990
HeadquartersՍան Ֆրանցիսկո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitenektar.com
Analyst ratings
Based on 9 analysts giving stock ratings to NKTR in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NKTR in the last 3 months.
Highest
Current 60,54 $
192,00 $ (+217,12%)
Average
139,14 $ (+129,81%)
Lowest
50,00 $ (-17,42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Julian Harrison
BTIG
Buy
Maintained
178,00 $
+194%
09/29/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
153,00 $
+152,7%
09/28/2026
Martin Fan
Wedbush
Hold
Reiterated
50,00 $
-17,4%
09/23/2026
Jessica Fye
J.P. Morgan
Hold
Initiated
65,00 $
+7,4%
08/21/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
192,00 $
+217,1%
08/20/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
185,00 $
+205,6%
08/17/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
08/14/2026
Samantha Semenkow
Citi
Buy
Maintained
151,00 $
+149,4%
08/14/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/13/2026
Jay Olson
Oppenheimer
Buy
Maintained
140,00 $
+131,2%
05/08/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
150,00 $
+147,7%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
11,79 մլն
21,81 մլն
10,86 մլն
10,13 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
27,25 մլն
29,71 մլն
35,68 մլն
39,13 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,07 մլն
11,18 մլն
13,44 մլն
12,76 մլն
Operating expense
43,32 մլն
40,90 մլն
49,12 մլն
51,89 մլն
Total operating expenses
43,32 մլն
40,90 մլն
49,12 մլն
51,89 մլն
Operating income
-31,53 մլն
-19,09 մլն
-38,26 մլն
-41,76 մլն
Other non operating income
-121,00 հզր
-44,00 հզր
-336,00 հզր
-100,00 հզր
EBT including unusual items
-35,56 մլն
-36,05 մլն
-44,84 մլն
-40,62 մլն
EBT excluding unusual items
-35,42 մլն
-27,47 մլն
-44,04 մլն
-40,04 մլն
Income tax expense
-33,00 հզր
31,00 հզր
64,00 հզր
2,00 հզր
Effective tax rate
0,09%
-0,09%
-0,14%
-
Other operating expenses
-
-
-
-
Net income
-35,52 մլն
-36,08 մլն
-44,90 մլն
-40,62 մլն
Net profit margin
-301,29%
-165,45%
-413,44%
-400,97%
Earnings per share
-1,87
-1,29
-1,78
-1,21
Interest and investment income
2,82 մլն
2,78 մլն
4,24 մլն
9,35 մլն
Interest expense
-6,05 մլն
-9,77 մլն
-7,94 մլն
-7,21 մլն
Net interest expenses
-3,23 մլն
-6,99 մլն
-3,70 մլն
2,14 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-31,34 մլն
-18,90 մլն
-38,11 մլն
-41,61 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps